Arbutus Biopharma Corp
NASDAQ:ABUS
Arbutus Biopharma Corp
NASDAQ:ABUS
Price:
4.52
USD
0.44%
Market Closed
Market Cap:
$869.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Arbutus Biopharma Corp
NASDAQ:ABUS
|
US |
|
VRX Silica Ltd
ASX:VRX
|
AU |
|
P
|
PLS Plantations Bhd
KLSE:PLS
|
MY |
|
PSC Corporation Ltd
SGX:DM0
|
SG |
|
Chill Brands Group PLC
LSE:CHLL
|
UK |
|
V
|
Victorian Plumbing Group PLC
LSE:VIC
|
UK |
|
Allstate Corp
NYSE:ALL
|
US |
|
BJ's Wholesale Club Holdings Inc
NYSE:BJ
|
US |
|
Intuit Inc
NASDAQ:INTU
|
US |
|
S
|
Satis Group SA
WSE:STS
|
PL |
|
XRF Scientific Ltd
ASX:XRF
|
AU |
|
Container Corporation of India Ltd
NSE:CONCOR
|
IN |
|
W
|
Watt's SA
SGO:WATTS
|
CL |
Multiples-Based Value
The Multiples-Based Value of one
ABUS
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 4.52 USD,
Arbutus Biopharma Corp
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ABUS Multiples-Based Value
LOCKED
Multiples Across Competitors
ABUS Competitors Multiples
Arbutus Biopharma Corp Competitors
Arbutus Biopharma Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Arbutus Biopharma Corp
NASDAQ:ABUS
|
870.2m USD | 61.8 | -26 | -31.5 | -31 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.1B USD | 6.2 | 90.8 | 15 | 20.8 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD | 5.2 | 24.7 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.1B USD | 5.9 | 20.5 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD | 9.5 | 28.7 | 21.6 | 22.6 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.2B USD | 5.7 | 18.2 | 13.7 | 15.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.5B EUR | 11.2 | 35.9 | 39 | 39.8 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
